Development of a recombinant antibody towards PAPP-A for immunohistochemical use in multiple animal species

Journal of Immunological Methods

Volumn 404, Issue 1, 2014, Pages 33-40

  Mikkelsen, Jakob H ^a   Steffensen, Lasse B ^a   Oxvig, Claus ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Affinity maturation; Immunohistochemistry; Pregnancy associated plasma protein A; Recombinant antibody

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 2; EPITOPE; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; PAC1 MIGG2A; PREGNANCY ASSOCIATED PLASMA PROTEIN A; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; CORONARY ARTERY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATURATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALIA; MURINAE; SUS;

AFFINITY MATURATION; IMMUNOHISTOCHEMISTRY; PREGNANCY-ASSOCIATED PLASMA-PROTEIN-A; RECOMBINANT ANTIBODY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; CONSERVED SEQUENCE; EPITOPES; FEMALE; FORMALDEHYDE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MICE; MOLECULAR SEQUENCE DATA; PARAFFIN EMBEDDING; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SINGLE-CHAIN ANTIBODIES; SWINE; TISSUE FIXATION;

EID: 84896737180     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.12.002     Document Type: Article

References (41)

1. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes D.R., Virmani R., Oxvig C., Schwartz R.S. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 2001, 345:1022.
2. Bayes-Genis A., Schwartz R.S., Lewis D.A., Overgaard M.T., Christiansen M., Oxvig C., Ashai K., Holmes D.R., Conover C.A. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler. Thromb. Vasc. Biol. 2001, 21:335.
3. Boldt H.B., Bale L.K., Resch Z.T., Oxvig C., Overgaard M.T., Conover C.A. Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice. Endocrinology 2013, 154:246.
4. Boldt H.B., Conover C.A. Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo. Endocrinology 2011, 152:1470.
5. Boldt H.B., Overgaard M.T., Laursen L.S., Weyer K., Sottrup-Jensen L., Oxvig C. Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem. J. 2001, 358:359.
6. Bonno M., Oxvig C., Kephart G.M., Wagner J.M., Kristensen T., Sottrup-Jensen L., Gleich G.J. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab. Invest. 1994, 71:560.
7. Bulut I., Coskun A., Ciftci A., Cetinkaya E., Altiay G., Caglar T., Gulcan E. Relationship between pregnancy-associated plasma protein-A and lung cancer. Am. J. Med. Sci. 2009, 337:241.
8. Chander H., Halpern M., Resnick-Silverman L., Manfredi J.J., Germain D. Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4. PLoS One 2011, 6:e22456.
9. Conover C.A., Bale L.K., Overgaard M.T., Johnstone E.W., Laursen U.H., Fuchtbauer E.M., Oxvig C., van Deursen J. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004, 131:1187.
10. Eaton B.E., Gold L., Zichi D.A. Let's get specific: the relationship between specificity and affinity. Chem. Biol. 1995, 2:633.
11. Forbes B.E., McCarthy P., Norton R.S. Insulin-like growth factor binding proteins: a structural perspective. Front. Endocrinol. (Lausanne) 2012, 3:38.
12. Gyrup C., Christiansen M., Oxvig C. Quantification of proteolytically active pregnancy-associated plasma protein-A with an assay based on quenched fluorescence. Clin. Chem. 2007, 53:947.
13. Harrington S.C., Simari R.D., Conover C.A. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ. Res. 2007, 100:1696.
14. Heidegger I., Pircher A., Klocker H., Massoner P. Targeting the insulin-like growth factor network in cancer therapy. Cancer Biol. Ther. 2011, 11:701.
15. Huang J., Tabata S., Kakiuchi S., The Van T., Goto H., Hanibuchi M., Nishioka Y. Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target. Oncotarget 2013, 4:1172.
16. Iversen K., Teisner A., Dalager S., Olsen K.E., Floridon C., Teisner B. Pregnancy associated plasma protein-A (PAPP-A) is not a marker of the vulnerable atherosclerotic plaque. Clin. Biochem. 2011, 44:312.
17. James L.C., Roversi P., Tawfik D.S. Antibody multispecificity mediated by conformational diversity. Science 2003, 299:1362.
18. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 1995, 16:3.
19. Kabat E.A., Wu T.T. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. J. Immunol. 1991, 147:1709.
20. Kristensen P., Winter G. Proteolytic selection for protein folding using filamentous bacteriophages. Fold. Des. 1998, 3:321.
21. Kuhajda F.P., Katumuluwa A.I., Pasternack G.R. Expression of haptoglobin-related protein and its potential role as a tumor antigen. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:1188.
22. Laursen L.S., Overgaard M.T., Soe R., Boldt H.B., Sottrup-Jensen L., Giudice L.C., Conover C.A., Oxvig C. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 2001, 504:36.
23. Lawrence J.B., Oxvig C., Overgaard M.T., Sottrup-Jensen L., Gleich G.J., Hays L.G., Yates J.R., Conover C.A. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:3149.
24. Lin T.M., Galbert S.P., Kiefer D., Spellacy W.N., Gall S. Characterization of four human pregnancy-associated plasma proteins. Am. J. Obstet. Gynecol. 1974, 118:223.
25. MacCallum R.M., Martin A.C., Thornton J.M. Antibody-antigen interactions: contact analysis and binding site topography. J. Mol. Biol. 1996, 262:732.
26. McLean G.R., Nakouzi A., Casadevall A., Green N.S. Human and murine immunoglobulin expression vector cassettes. Mol. Immunol. 2000, 37:837.
27. Mikkelsen J.H., Gyrup C., Kristensen P., Overgaard M.T., Poulsen C.B., Laursen L.S., Oxvig C. Inhibition of the proteolytic activity of pregnancy-associated plasma protein-A by targeting substrate exosite binding. J. Biol. Chem. 2008, 283:16772.
28. Monget P., Mazerbourg S., Delpuech T., Maurel M.C., Maniere S., Zapf J., Lalmanach G., Oxvig C., Overgaard M.T. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol. Reprod. 2003, 68:77.
29. Overgaard M.T., Haaning J., Boldt H.B., Olsen I.M., Laursen L.S., Christiansen M., Gleich G.J., Sottrup-Jensen L., Conover C.A., Oxvig C. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J. Biol. Chem. 2000, 275:31128.
30. Overgaard M.T., Oxvig C., Christiansen M., Lawrence J.B., Conover C.A., Gleich G.J., Sottrup-Jensen L., Haaning J. Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biol. Reprod. 1999, 61:1083.
31. Oxvig C. Pappalysin-1 (Pregnancy-Associated Plasma Protein-A). Handbook of Proteolytic Enzymes 2013, 1212. Elsevier.
32. Oxvig C., Sand O., Kristensen T., Gleich G.J., Sottrup-Jensen L. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J. Biol. Chem. 1993, 268:12243.
33. Pan H., Hanada S., Zhao J., Mao L., Ma M.Z. Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo. PLoS One 2012, 7:e48799.
34. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 2008, 8:915.
35. Prassler J., Steidl S., Urlinger S. In vitro affinity maturation of HuCAL antibodies: complementarity determining region exchange and RapMAT technology. Immunotherapy 2009, 1:571.
36. Qin Q.P., Christiansen M., Oxvig C., Pettersson K., Sottrup-Jensen L., Koch C., Norgaard-Pedersen B. Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. Clin. Chem. 1997, 43:2323.
37. Ryan A.J., Napoletano S., Fitzpatrick P.A., Currid C.A., O'Sullivan N.C., Harmey J.H. Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer. Br. J. Cancer 2009, 101:278.
38. Sangiorgi G., Mauriello A., Bonanno E., Oxvig C., Conover C.A., Christiansen M., Trimarchi S., Rampoldi V., Holmes D.R., Schwartz R.S., Spagnoli L.G. Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J. Am. Coll. Cardiol. 2006, 47:2201.
39. Sitar T., Popowicz G.M., Siwanowicz I., Huber R., Holak T.A. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13028.
40. Wedemayer G.J., Patten P.A., Wang L.H., Schultz P.G., Stevens R.C. Structural insights into the evolution of an antibody combining site. Science 1997, 276:1665.
41. Weyer K., Boldt H.B., Poulsen C.B., Kjaer-Sorensen K., Gyrup C., Oxvig C. A substrate specificity-determining unit of three Lin12-Notch repeat modules is formed in trans within the pappalysin-1 dimer and requires a sequence stretch C-terminal to the third module. J. Biol. Chem. 2007, 282:10988.